American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Walt Disney
DIS
|
+$412M |
| 2 |
Verizon
VZ
|
+$402M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$273M |
| 4 |
Invesco
IVZ
|
+$201M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$193M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$415M |
| 2 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$291M |
| 3 |
PepsiCo
PEP
|
+$245M |
| 4 |
AT&T
T
|
+$243M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$201M |
Sector Composition
| 1 | Financials | 13.15% |
| 2 | Healthcare | 12.24% |
| 3 | Industrials | 12.06% |
| 4 | Technology | 10.99% |
| 5 | Consumer Discretionary | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Western Union
WU
$2.71B
| $1.07M | ﹤0.01% |
61,393
| – | – |
|
|
KERX
1202
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.06M | ﹤0.01% |
68,584
-2,380
| -3% | -$36.6K |
|
|
ARNA
1203
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.05M | ﹤0.01% |
17,904
+3,937
| +28% | +$231K |
|
1204
TFS Financial
TFSL
$3.75B
| $1.04M | ﹤0.01% |
73,071
-16,338
| -18% | -$233K |
|
1205
HCI Group
HCI
$2.34B
| $1.04M | ﹤0.01% |
25,515
-109,410
| -81% | -$4.44M |
|
|
CSS
1206
DELISTED
CSS Industries, Inc.
CSS
| $1.04M | ﹤0.01% |
39,249
+5,730
| +17% | +$151K |
|
|
ESC
1207
DELISTED
EMERITUS CORP
ESC
| $1.04M | ﹤0.01% |
32,706
-2,613
| -7% | -$82.7K |
|
1208
WESCO International
WCC
$10.4B
| $1.03M | ﹤0.01% |
11,929
-337
| -3% | -$29.1K |
|
1209
Celldex Therapeutics
CLDX
$1.62B
| $1.02M | ﹤0.01% |
4,162
-738
| -15% | -$181K |
|
1210
Jazz Pharmaceuticals
JAZZ
$7.65B
| $1.01M | ﹤0.01% |
6,891
-380
| -5% | -$55.9K |
|
1211
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $1.01M | ﹤0.01% |
10,600
| – | – |
|
|
MTOR
1212
DELISTED
MERITOR, Inc.
MTOR
| $1.01M | ﹤0.01% |
+77,124
| New | +$1.01M |
|
|
CMD
1213
DELISTED
Cantel Medical Corporation
CMD
| $1M | ﹤0.01% |
+27,410
| New | +$1M |
|
1214
Omnicell
OMCL
$1.46B
| $991K | ﹤0.01% |
+34,509
| New | +$991K |
|
|
FTR
1215
DELISTED
Frontier Communications Corp.
FTR
| $990K | ﹤0.01% |
11,299
-22,304
| -66% | -$1.95M |
|
1216
Sarepta Therapeutics
SRPT
$1.82B
| $988K | ﹤0.01% |
+33,182
| New | +$988K |
|
|
RLD
1217
DELISTED
REALD INC COM STK
RLD
| $987K | ﹤0.01% |
+77,357
| New | +$987K |
|
|
FMBI
1218
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $984K | ﹤0.01% |
57,758
+4,370
| +8% | +$74.5K |
|
|
ACAT
1219
DELISTED
Arctic Cat Inc
ACAT
| $979K | ﹤0.01% |
24,830
+4,540
| +22% | +$179K |
|
|
I
1220
DELISTED
INTELSAT S. A.
I
| $968K | ﹤0.01% |
+51,369
| New | +$968K |
|
|
ORB
1221
DELISTED
ORBITAL SCIENCES CORP
ORB
| $965K | ﹤0.01% |
32,656
+2,603
| +9% | +$76.9K |
|
1222
Select Medical
SEM
$1.55B
| $959K | ﹤0.01% |
+114,077
| New | +$959K |
|
1223
Masimo
MASI
$8.01B
| $957K | ﹤0.01% |
40,540
+220
| +0.5% | +$5.19K |
|
|
EXAM
1224
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $948K | ﹤0.01% |
+29,885
| New | +$948K |
|
1225
Telephone and Data Systems
TDS
$4.51B
| $943K | ﹤0.01% |
36,101
-1,709
| -5% | -$44.6K |
|